Publicaciones en las que colabora con Francisco Jorquera Plaza (31)

2024

  1. Idiosyncratic Drug-Induced Liver Injury and Amoxicillin–Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

2021

  1. Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old

    Clinical Pharmacology and Therapeutics, Vol. 109, Núm. 4, pp. 1147-1158

  2. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

    Journal of Hepatology, Vol. 75, Núm. 1, pp. 86-97

2019

  1. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 275-282

  2. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

    Molecular Nutrition and Food Research, Vol. 63, Núm. 8

2018

  1. Analysis of bone mineral density in children with celiac disease. Densitometry indications and effect of gluten-free diet

    Nutricion Hospitalaria, Vol. 35, Núm. 3, pp. 543-549

  2. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

    Clinical Gastroenterology and Hepatology, Vol. 16, Núm. 9, pp. 1495-1502

2014

  1. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin

    Laboratory Investigation, Vol. 94, Núm. 3, pp. 262-274

2012

  1. Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication

    Laboratory Investigation, Vol. 92, Núm. 8, pp. 1191-1202

  2. Tendencia y distribución municipal de la incidencia de cáncer colorrectal en el área de salud de León (1994-2008)

    Gastroenterologia y Hepatologia, Vol. 35, Núm. 5, pp. 299-308

2011

  1. Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus

    Journal of Pineal Research, Vol. 50, Núm. 1, pp. 38-45

2010

  1. Signaling pathways involved in liver injury and regeneration in rabbit hemorrhagic disease, an animal model of virally-induced fulminant hepatic failure

    Veterinary Research, Vol. 41, Núm. 1

2008

  1. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line

    Journal of Pineal Research, Vol. 45, Núm. 4, pp. 532-540

2005

  1. Effects of parenteral nutrition supplemented with alanyl-glutamine on nutrition status in rats

    Journal of Parenteral and Enteral Nutrition, Vol. 29, Núm. 4, pp. 262-265

  2. Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C

    Journal of Gastroenterology and Hepatology (Australia), Vol. 20, Núm. 4, pp. 547-554

2004

  1. Influencia de la formulación de la glutamina en sus efectos sobre los sistemas antioxidantes y de destoxificación hepática en la rata

    Nutricion Hospitalaria, Vol. 19, Núm. 2, pp. 73-82

2003

  1. Caspase inhibition does not protect against liver damage in hemorrhagic shock.

    Shock (Augusta, Ga.), Vol. 19, Núm. 1, pp. 33-37

  2. Rabbit hemorrhagic viral disease: Characterization of a new animal model of fulminant liver failure

    Journal of Laboratory and Clinical Medicine, Vol. 141, Núm. 4, pp. 272-278

  3. TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor Kappa B activation in a rat model of hepatocellular carcinoma

    Free Radical Research, Vol. 37, Núm. 8, pp. 841-848

2001

  1. Antipyrine clearance and metabolite formation in primary biliary cirrhosis

    Digestive Diseases and Sciences, Vol. 46, Núm. 2, pp. 352-359